Apoptosis regulation and drug resistance in malignant pleural mesothelioma

Lung Cancer

Volumn 49, Issue SUPPL. 1, 2005, Pages

  Zangemeister Wittke, Uwe ^a   Hopkins Donaldson, Sally ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GEMCITABINE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; HUMAN; MALIGNANT MESOTHELIOMA; NONHUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; REGULATORY MECHANISM;

APOPTOSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS;

EID: 20444389044     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.019     Document Type: Article

References (20)

1. J. Peto, A. Decarli, C. La Vecchia, F. Levi, and E. Negri The European mesothelioma epidemic Br J Cancer 79 1999 666 672
2. M. Carbone, R.A. Kratzke, and J.R. Testa The pathogenesis of mesothelioma Semin Oncol 29 2002 2 17
3. P. Baas Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine Semin Oncol 29 2002 62 69
4. K. Kim, R. Takimoto, D.T. Dicker, Y.H. Chen, Y. Gazitt, and W.S. El Deiry Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines Int J Oncol 18 2001 241 247
5. D.L. Vaux, and J. Silke Mammalian mitochondrial IAP binding proteins Biochem Biophys Res Commun 304 2003 499 504
6. A.A. Sandberg, and J.A. Bridge Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma Cancer Genet Cytogenet 127 2001 93 110
7. P.B. Illei, M.F. Zakowski, M. Ladanyi, and V.W. Rusch Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas Clin Cancer Res 9 2003 2108 2113
8. F. Lopez-Rios, P.B. Illei, V. Rusch, and M. Ladanyi Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids Lancet 364 2004 1157 1166
9. D.A. Fennell, M.V. Corbo, N.M. Dean, B.P. Monia, and F.E. Cotter In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model Br J Haematol 112 2001 706 713
10. U.A. Sartorius, and P.H. Krammer Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines Int J Cancer 97 2002 584 592
11. S. Hopkins-Donaldson, R. Cathomas, A.P. Simoes-Wust, S. Kurtz, L. Belyanskya, and R.A. Stahel Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment Int J Cancer 106 2003 160 166
12. C. Xia, Z. Xu, X. Yuan, K. Uematsu, L. You, and K. Li Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides Mol Cancer Ther 1 2002 687 694
13. Altieri DC Cytokinesis, apoptosis and survivin: three for tango Cell Death Differ 8 2001 4 5
14. M. Mesri, N.R. Wall, J. Li, R.W. Kim, and D.C. Altieri Cancer gene therapy using a survivin mutant adenovirus J Clin Invest 108 2001 981 990
15. R.A. Olie, A.P. Simoes-Wust, B. Baumann, S.H. Leech, D. Fabbro, and R.A. Stahel A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res 60 2000 2805 2809
16. M. Ikeguchi, J. Liu, and N. Kaibara Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment Apoptosis 7 2002 23 29
17. A. Catalano, L. Graciotti, L. Rinaldi, G. Raffaelli, S. Rodilossi, and P. Betta Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention Int J Cancer 109 2004 322 328
18. P.A. Janne, M.L. Taffaro, R. Salgia, and B.E. Johnson Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma Cancer Res 62 2002 5242 5247
19. I. Mohiuddin, X. Cao, M.K. Ozvaran, L. Zumstein, S. Chada, and W.R. Smythe Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation Ann Surg Oncol 9 2002 310 316
20. K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein p21/CDKN1A mediates negative regulation of transcription by p53 J Biol Chem 278 2003 32507 32516